Chu and others [ 20] also discussed a trivariate nonlinear random-effects model for jointly modeling disease prevalence, sensitivity and specificity, as well as an alternative parameterization for jointly modeling prevalence and predictive values.
However, this "problem" with using the prevalence ratio is more imaginary than real because standard methods can be used to model prevalences, just as they can be used to model risks (both prevalence and risk are expressed as a proportion; Tables 1 and 2).
Specifically, we reason that projections or comparisons of prevalence-based healthy life expectancy (HLE) are in many cases biased in period prevalence-based models unless one takes into account the thanatological age pattern of prevalence, as well as mortality differences.
Trisomy 13 is not included in the model because of its lower prevalence, as well as imprecise or biased estimates for detection and false-positive rates.
Alternative treatments are rising in popularity and prevalence, as well.
Using a model of prevalence as a function of incidence, survival and population demographics, projections were made to 2040.
Using a model of prevalence as a function of incidence, survival and population demographics, Maddams et al projected that by 2040, the number of cancer survivors in the United Kingdom will increase by approximately one million per decade[ 1].
For this BMI category, in our unadjusted models, prevalence of dysglycemia was twice as high in both non-Hispanic blacks and Mexican Americans compared with non-Hispanic whites.
Our work attempts to estimate trends in HCV prevalence and models prevalence in recent (<1 year) injectors as a measure of incidence, but another possible approach would be to estimate incidence directly from serial prevalence and exposure information (e.g., refer to references 32 and 33).
The analysis reported in figure 2 showed that the change of anti-HEV IgG prevalence throughout the period could be, at best, described by a multivariate logistic model which included year of sampling as a cubic term, modelling the variations of prevalence as a fluctuation with a period of about 3 years (p=0.032).
